Systolic Hypertension in the Elderly Program "SHEP"

Completed

Phase N/A Results

Summary of Purpose

To investigate antihypertensive drug treatment effects on incidence of stroke in elderly patients with isolated systolic hypertension.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Heart, Lung, and Blood Institute and the National Institute on Aging

Trial Design

Randomized, stratified, double-blind, placebo-controlled trial of 4736 patients at 16 centers. Stratification was by clinical center and by antihypertensive medication status at initial contact.

Contacts

  • H. Mitchell Perry, Jr, MD, Washington University, Box 8048, 660 S Euclid Ave, St Louis, MO 63110, USA.

    mperry@imgate.wustl.edu